Dr David Cutter
Clinical Research Fellow (CTSU) and Consultant Clinical Oncologist (Oxford Cancer Centre)
David Cutter studied medicine at the University of Cambridge (1994-2000) and trained in Oncology at the Oxford Cancer Centre. In 2008 he joined CTSU to study for a DPhil on the late cardiovascular effects of cancer treatments. In 2013 he was appointed as a Consultant Clinical Oncologist and continues to work within CTSU upon a programme of work investigating the benefits and risks of cancer treatments.
Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.
Taylor C. et al, (2018), J Clin Oncol, 36, 2288 - 2296
Radiation-induced cardiac toxicity: what have we learnt?
Cutter D., (2018), RADIOTHERAPY AND ONCOLOGY, 127, S1 - S1
Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up.
Frobisher C. et al, (2017), Br J Cancer, 117, 1723 - 1731
Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
Tseng YD. et al, (2017), Int J Radiat Oncol Biol Phys, 99, 825 - 842
Predicted Cardiac and Second Cancer Risks in Hodgkin Lymphoma Patients Treated With Advanced Proton Beam Therapy Compared to Photon Radiation Therapy
Ntentas G. et al, (2017), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99, S181 - S181